- Home
- FGBI vs BIOA Comparison
FGBI vs BIOA Comparison
Compare FGBI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGBI
- BIOA
- Stock Information
- Founded
- FGBI 1934
- BIOA 2015
- Country
- FGBI United States
- BIOA United States
- Employees
- FGBI N/A
- BIOA N/A
- Industry
- FGBI Savings Institutions
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- FGBI Finance
- BIOA Health Care
- Exchange
- FGBI Nasdaq
- BIOA Nasdaq
- Market Cap
- FGBI 131.1M
- BIOA 144.1M
- IPO Year
- FGBI N/A
- BIOA 2024
- Fundamental
- Price
- FGBI $9.61
- BIOA $4.04
- Analyst Decision
- FGBI
- BIOA Hold
- Analyst Count
- FGBI 0
- BIOA 4
- Target Price
- FGBI N/A
- BIOA $5.67
- AVG Volume (30 Days)
- FGBI 26.9K
- BIOA 235.4K
- Earning Date
- FGBI 05-20-2025
- BIOA 05-06-2025
- Dividend Yield
- FGBI 2.71%
- BIOA N/A
- EPS Growth
- FGBI N/A
- BIOA N/A
- EPS
- FGBI 0.13
- BIOA N/A
- Revenue
- FGBI $81,298,000.00
- BIOA $1,451,000.00
- Revenue This Year
- FGBI $2.30
- BIOA N/A
- Revenue Next Year
- FGBI $2.98
- BIOA N/A
- P/E Ratio
- FGBI $73.14
- BIOA N/A
- Revenue Growth
- FGBI N/A
- BIOA N/A
- 52 Week Low
- FGBI $6.56
- BIOA $2.88
- 52 Week High
- FGBI $15.25
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- FGBI 55.21
- BIOA N/A
- Support Level
- FGBI $9.05
- BIOA N/A
- Resistance Level
- FGBI $10.55
- BIOA N/A
- Average True Range (ATR)
- FGBI 0.55
- BIOA 0.00
- MACD
- FGBI -0.08
- BIOA 0.00
- Stochastic Oscillator
- FGBI 39.74
- BIOA 0.00
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.